Eledon Pharmaceuticals, Inc.
ELDN
$2.82
-$0.11-3.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.64M | 3.98M | 3.99M | 4.10M | 4.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.87M | 21.18M | 21.48M | 19.07M | 24.73M |
| Operating Income | -22.87M | -21.18M | -21.48M | -19.07M | -24.73M |
| Income Before Tax | -31.63M | -39.03M | -10.41M | -17.46M | -11.22M |
| Income Tax Expenses | -- | -- | 35.00K | -- | -- |
| Earnings from Continuing Operations | -31.63M | -39.03M | -10.45M | -17.46M | -11.22M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.63M | -39.03M | -10.45M | -17.46M | -11.22M |
| EBIT | -22.87M | -21.18M | -21.48M | -19.07M | -24.73M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.28 | -0.35 | -0.11 | -0.23 | -0.15 |
| Normalized Basic EPS | -0.17 | -0.22 | -0.07 | -0.14 | -0.09 |
| EPS Diluted | -0.28 | -0.35 | -0.11 | -0.23 | -0.15 |
| Normalized Diluted EPS | -0.17 | -0.22 | -0.07 | -0.14 | -0.09 |
| Average Basic Shares Outstanding | 113.73M | 112.54M | 96.02M | 77.27M | 77.27M |
| Average Diluted Shares Outstanding | 113.73M | 112.54M | 96.02M | 77.27M | 77.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |